Outpatient management of heart valve disease following the COVID-19 pandemic: implications for present and future care

Guidance is presented on identification of stable patients that could have follow-up deferred safely and suggest certain patients that could be discharged from follow-up if waiting lists are triaged with appropriate clinical input. Novel models of working are also proposed.